{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T12:41:40Z","timestamp":1772887300722,"version":"3.50.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2008,8,19]],"date-time":"2008-08-19T00:00:00Z","timestamp":1219104000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Calcif Tissue Int"],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1007\/s00223-008-9161-2","type":"journal-article","created":{"date-parts":[[2008,8,18]],"date-time":"2008-08-18T20:40:46Z","timestamp":1219092046000},"page":"167-175","source":"Crossref","is-referenced-by-count":33,"title":["Short-Term Effects of High-Dose Zoledronic Acid Treatment on Bone Mineralization Density Distribution After Orthotopic Liver Transplantation"],"prefix":"10.1007","volume":"83","author":[{"given":"B. M.","family":"Misof","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Bodingbauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Roschger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Wekerle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Pakrah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Haas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Kainz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Oberbauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"M\u00fchlbacher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Klaushofer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,8,19]]},"reference":[{"key":"9161_CR1","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/ncpgasthep0637","volume":"3","author":"BA Crawford","year":"2006","unstructured":"Crawford BA, Labio ED, Strasser SI, McCaughan GW (2006) Vitamin D replacement for cirrhosis related bone disease. Nat Clin Pract Gastroenterol Hepatol 3:689\u2013699","journal-title":"Nat Clin Pract Gastroenterol Hepatol"},{"key":"9161_CR2","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/S0168-8278(03)00143-0","volume":"38","author":"JE Hay","year":"2003","unstructured":"Hay JE (2003) Osteoporosis in liver diseases and after liver transplantation. J Hepatol 38:856\u2013865","journal-title":"J Hepatol"},{"key":"9161_CR3","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1007\/s002239900205","volume":"60","author":"A Monegal","year":"1997","unstructured":"Monegal A, Navasa M, Guanabens N, Peris P, Pons F, Martinez de Osaba MJ, Rimola A, Rodes J, Munoz-Gomez J (1997) Osteoporosis and bone mineral metabolism disorders in cirrhotic patients referred for orthotopic liver transplantation. Calcif Tissue Int 60:148\u2013154","journal-title":"Calcif Tissue Int"},{"key":"9161_CR4","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1359\/jbmr.2003.18.12.2190","volume":"18","author":"MM Guichelaar","year":"2003","unstructured":"Guichelaar MM, Malinchoc M, Sibonga JD, Clarke BL, Hay JE (2003) Bone histomorphometric changes after liver transplantation for chronic cholestatic liver disease. J Bone Miner Res 18:2190\u20132199","journal-title":"J Bone Miner Res"},{"key":"9161_CR5","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1002\/lt.20466","volume":"11","author":"G Millonig","year":"2005","unstructured":"Millonig G, Graziadei IW, Eichler D, Pfeiffer KP, Finkenstedt G, Muehllechner P, Koenigsrainer A, Margreiter R, Vogel W (2005) Alendronate in combination with calcium and vitamin D prevents bone loss after orthotopic liver transplantation: a prospective single-center study. Liver Transpl 11:960\u2013966","journal-title":"Liver Transpl"},{"key":"9161_CR6","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1007\/BF02556312","volume":"44","author":"GL Klein","year":"1989","unstructured":"Klein GL, Endres DB, Colonna JDII, Berquist WE, Goldstein LI, Busuttil RW, Deftos LJ (1989) Absence of hyperparathyroidism in severe liver disease. Calcif Tissue Int 44:330\u2013334","journal-title":"Calcif Tissue Int"},{"key":"9161_CR7","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1007\/s001980170094","volume":"12","author":"A Monegal","year":"2001","unstructured":"Monegal A, Navasa M, Guanabens N, Peris P, Pons F, Martinez de Osaba MJ, Ordi J, Rimola A, Rodes J, Munoz-Gomez J (2001) Bone disease after liver transplantation: a long-term prospective study of bone mass changes, hormonal status and histomorphometric characteristics. Osteoporos Int 12:484\u2013492","journal-title":"Osteoporos Int"},{"key":"9161_CR8","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0016-5085(89)90783-X","volume":"96","author":"TH Diamond","year":"1989","unstructured":"Diamond TH, Stiel D, Lunzer M, McDowall D, Eckstein RP, Posen S (1989) Hepatic osteodystrophy. Static and dynamic bone histomorphometry and serum bone Gla-protein in 80 patients with chronic liver disease. Gastroenterology 96:213\u2013221","journal-title":"Gastroenterology"},{"key":"9161_CR9","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1053\/jhep.2002.36357","volume":"36","author":"MM Guichelaar","year":"2002","unstructured":"Guichelaar MM, Malinchoc M, Sibonga J, Clarke BL, Hay JE (2002) Bone metabolism in advanced cholestatic liver disease: analysis by bone histomorphometry. Hepatology 36:895\u2013903","journal-title":"Hepatology"},{"key":"9161_CR10","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/hep.1840140209","volume":"14","author":"JE Hay","year":"1991","unstructured":"Hay JE, Lindor KD, Wiesner RH, Dickson ER, Krom RA, LaRusso NF (1991) The metabolic bone disease of primary sclerosing cholangitis. Hepatology 14:257\u2013261","journal-title":"Hepatology"},{"key":"9161_CR11","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/hep.1840140407","volume":"14","author":"JA McDonald","year":"1991","unstructured":"McDonald JA, Dunstan CR, Dilworth P, Sherbon K, Sheil AG, Evans RA, McCaughan GW (1991) Bone loss after liver transplantation. Hepatology 14:613\u2013619","journal-title":"Hepatology"},{"key":"9161_CR12","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1002\/lt.20874","volume":"12","author":"MJ Guichelaar","year":"2006","unstructured":"Guichelaar MJ, Kendall R, Malinchoc M, Hay JE (2006) Bone mineral density before and after OLT: long-term follow-up and predictive factors. Liver Transpl 12:1390\u20131402","journal-title":"Liver Transpl"},{"key":"9161_CR13","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1359\/jbmr.040912","volume":"19","author":"A Cohen","year":"2004","unstructured":"Cohen A, Sambrook P, Shane E (2004) Management of bone loss after organ transplantation. J Bone Miner Res 19:1919\u20131932","journal-title":"J Bone Miner Res"},{"key":"9161_CR14","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1089\/15246090050118125","volume":"9","author":"E Siris","year":"2000","unstructured":"Siris E (2000) Alendronate in the treatment of osteoporosis: a review of the clinical trials. J Womens Health Gender-Based Med 9:599\u2013606","journal-title":"J Womens Health Gender-Based Med"},{"key":"9161_CR15","doi-asserted-by":"crossref","first-page":"239","DOI":"10.7326\/0003-4819-144-4-200602210-00005","volume":"144","author":"BAL Crawford","year":"2006","unstructured":"Crawford BAL, Kam C, Pavlovic J, Byth K, Handelsman DJ, Angus PW, McCaughan GW (2006) Zoledronic acid prevents bone loss after liver transplantation: a randomized, double-blind, placebo-controlled trial. Ann Intern Med 144:239\u2013248","journal-title":"Ann Intern Med"},{"key":"9161_CR16","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1111\/j.1600-6143.2007.01844.x","volume":"7","author":"M Bodingbauer","year":"2007","unstructured":"Bodingbauer M, Wekerle T, Pakrah B, Silberhumer G, Roschger P, Peck-Radosavljevic M, Grampp S, Rockenschaub S, Berlakovich G, Steininger R, Klaushofer K, Oberbauer R, M\u00fchlbacher F (2007) Prophylactic bisphosphonate treatment prevents bone fractures after liver transplantation. Am J Transplant 7:1763\u20131769","journal-title":"Am J Transplant"},{"key":"9161_CR17","first-page":"538","volume":"2","author":"G Boivin","year":"2002","unstructured":"Boivin G, Meunier PJ (2002) Effects of bisphosphonates on matrix mineralization. J Musculoskelet Neuronal Interact 2:538\u2013543","journal-title":"J Musculoskelet Neuronal Interact"},{"key":"9161_CR18","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.bone.2006.01.161","volume":"39","author":"B Borah","year":"2006","unstructured":"Borah B, Dufresne TE, Ritman EL, Jorgensen SM, Liu S, Chmielewski PA, Phipps RJ, Zhou X, Sibonga JD, Turner RT (2006) Long-term risedronate treatment normalizes mineralization and continues to preserve trabecular architecture: sequential triple biopsy studies with micro-computed tomography. Bone 39:345\u2013352","journal-title":"Bone"},{"key":"9161_CR19","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0221-8747(83)90016-4","volume":"5","author":"A Boyde","year":"1983","unstructured":"Boyde A, Jones SJ (1983) Backscattered electron imaging of skeletal tissues. Metab Bone Dis Rel Res 5:145\u2013150","journal-title":"Metab Bone Dis Rel Res"},{"key":"9161_CR20","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S8756-3282(98)00112-4","volume":"23","author":"P Roschger","year":"1998","unstructured":"Roschger P, Fratzl P, Eschberger J, Klaushofer K (1998) Validation of quantitative backscattered electron imaging for the measurement of mineral density distribution in human bone biopsies. Bone 23:319\u2013326","journal-title":"Bone"},{"key":"9161_CR21","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1515\/9781400849505","volume-title":"Bones: structure and mechanics","author":"JD Currey","year":"2002","unstructured":"Currey JD (2002) Bones: structure and mechanics. Princeton University Press, Princeton, NJ, p 436"},{"key":"9161_CR22","unstructured":"Fratzl P, Gupta HS, Roschger P, Klaushofer K (2008) Bone nanostructure and its relevance for mechanical performance, disease and treatment. In: Vogel V (ed) Nanotechnology-nanomedicine and nanobiotechnology, Wiley-VCH, Weinheim, Germany (in press)"},{"key":"9161_CR23","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/S8756-3282(02)00973-0","volume":"32","author":"P Roschger","year":"2003","unstructured":"Roschger P, Gupta HS, Berzlanovich A, Ittner G, Dempster DW, Fratzl P, Cosman F, Parisien M, Lindsay R, Nieves JW, Klaushofer K (2003) Constant mineralization density distribution in cancellous human bone. Bone 32:316\u2013323","journal-title":"Bone"},{"key":"9161_CR24","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.bone.2007.10.021","volume":"42","author":"P Roschger","year":"2008","unstructured":"Roschger P, Paschalis EP, Fratzl P, Klaushofer K (2008) Bone mineralization density distribution in health and disease. Bone 42:456\u2013466","journal-title":"Bone"},{"key":"9161_CR25","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S8756-3282(01)00485-9","volume":"29","author":"P Roschger","year":"2001","unstructured":"Roschger P, Rinnerthaler S, Yates J, Rodan GA, Fratzl P, Klaushofer K (2001) Alendronate increases degree and uniformity of mineralization in cancellous bone and decreases the porosity in cortical bone of osteoporotic women. Bone 29:185\u2013191","journal-title":"Bone"},{"key":"9161_CR26","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1359\/jbmr.060401","volume":"21","author":"R Zoehrer","year":"2006","unstructured":"Zoehrer R, Roschger P, Paschalis EP, Hofstaetter JG, Durchschlag E, Fratzl P, Phipps R, Klaushofer K (2006) Effects of 3- and 5-year treatment with risedronate on bone mineralization density distribution in triple biopsies of the iliac crest in postmenopausal women. J Bone Miner Res 21:1106\u20131112","journal-title":"J Bone Miner Res"},{"key":"9161_CR27","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1046\/j.1523-1755.2003.00816.x","volume":"63","author":"M Haas","year":"2003","unstructured":"Haas M, Leko-Mohr Z, Roschger P, Kletzmayr J, Schwarz C, Mitterbauer C, Steininger R, Grampp S, Klaushofer K, Delling G, Oberbauer R (2003) Zoledronic acid to prevent bone loss in the first six months after renal transplantation. Kidney Int 63:1130\u20131136","journal-title":"Kidney Int"},{"key":"9161_CR28","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/jbmr.5650020617","volume":"2","author":"AM Parfitt","year":"1987","unstructured":"Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ et al (1987) Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 2:595\u2013610","journal-title":"J Bone Miner Res"},{"key":"9161_CR29","volume-title":"The measurement of metabolic bone disease. Measurements in medicine series","author":"FI Tovey","year":"1995","unstructured":"Tovey FI, Stamp TCB (1995) The measurement of metabolic bone disease. Measurements in medicine series, vol 1. Parthenon Publishing Group, Carnforth, UK"},{"key":"9161_CR30","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1210\/jc.2002-021988","volume":"88","author":"BM Misof","year":"2003","unstructured":"Misof BM, Roschger P, Cosman F, Kurland ES, Tesch W, Messmer P, Dempster DW, Nieves J, Shane E, Fratzl P, Klaushofer K, Bilezikian JP, Lindsay R (2003) Effects of intermittent parathyroid hormone administration on bone mineralization density in iliac crest biopsies from patients with osteoporosis: a paired study before and after treatment. J Clin Endocrinol Metab 88:1150\u20131156","journal-title":"J Clin Endocrinol Metab"},{"key":"9161_CR31","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1359\/jbmr.070120","volume":"22","author":"P Roschger","year":"2007","unstructured":"Roschger P, Dempster DW, Zhou H, Paschalis EP, Silverberg SJ, Shane E, Bilezikian JP, Klaushofer K (2007) New observations on bone quality in mild hyperparathyroidism as determined by quantitative backscattered electron imaging. J Bone Miner Res 22:717\u2013723","journal-title":"J Bone Miner Res"},{"key":"9161_CR32","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s00223-007-9039-8","volume":"81","author":"P Fratzl","year":"2007","unstructured":"Fratzl P, Roschger P, Fratzl-Zelman N, Paschalis EP, Phipps R, Klaushofer K (2007) Evidence that treatment with risedronate in women with postmenopausal osteoporosis affects bone mineralization and bone volume. Calcif Tissue Int 81:73\u201380","journal-title":"Calcif Tissue Int"},{"key":"9161_CR33","doi-asserted-by":"crossref","first-page":"3331","DOI":"10.1210\/jc.2004-2042","volume":"90","author":"MA Donovan","year":"2005","unstructured":"Donovan MA, Dempster D, Zhou H, McMahon DJ, Fleischer J, Shane E (2005) Low bone formation in premenopausal women with idiopathic osteoporosis. J Clin Endocrinol Metab 90:3331\u20133336","journal-title":"J Clin Endocrinol Metab"},{"key":"9161_CR34","unstructured":"Roschger P, Manjubala I, Hofstaetter JG, Shane E, Donovan MA, Fleischer J, Dempster D, Fratzl P, Klaushofer K (2005) Reduced mineralization density of bone in premenopausal women with idiopathic osteoporosis. Twenty-seventh annual meeting of the American Society for Bone and Mineral Research, Nashville, TN, September 23\u201327, 2005 [abstract]"},{"key":"9161_CR35","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1002\/lt.20160","volume":"10","author":"MM Guichelaar","year":"2004","unstructured":"Guichelaar MM, Malinchoc M, Sibonga J, Clarke BL, Hay JE (2004) Immunosuppressive and postoperative effects of orthotopic liver transplantation on bone metabolism. Liver Transpl 10:638\u2013647","journal-title":"Liver Transpl"},{"key":"9161_CR36","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/j.1432-2277.2002.tb00167.x","volume":"15","author":"S Vedi","year":"2002","unstructured":"Vedi S, Ninkovic M, Garrahan NJ, Alexander GJM, Compston JE (2002) Effects of a single infusion of pamidronate prior to liver transplantation: a bone histomorphometric study. Transpl Int 15:290\u2013295","journal-title":"Transpl Int"},{"key":"9161_CR37","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/j.bone.2007.01.012","volume":"40","author":"D Ruffoni","year":"2007","unstructured":"Ruffoni D, Fratzl P, Roschger P, Klaushofer K, Weinkamer R (2007) The bone mineralization density distribution as a fingerprint of the mineralization process. Bone 40:1308\u20131319","journal-title":"Bone"},{"key":"9161_CR38","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1359\/jbmr.1999.14.2.281","volume":"14","author":"S Vedi","year":"1999","unstructured":"Vedi S, Greer S, Skingle SJ, Garrahan NJ, Ninkovic M, Alexander GA, Compston JE (1999) Mechanism of bone loss after liver transplantation: a histomorphometric analysis. J Bone Miner Res 14:281\u2013287","journal-title":"J Bone Miner Res"},{"key":"9161_CR39","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1136\/gut.44.3.430","volume":"44","author":"OM Crosbie","year":"1999","unstructured":"Crosbie OM, Freaney R, McKenna MJ, Curry MP, Hegarty JE (1999) Predicting bone loss following orthotopic liver transplantation. Gut 44:430\u2013434","journal-title":"Gut"},{"key":"9161_CR40","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1359\/jbmr.071101","volume":"23","author":"PR Ebeling","year":"2008","unstructured":"Ebeling PR, Burr DB (2008) Positive effects of intravenous zoledronic acid on bone remodeling and structure: are different effects on osteoblast activity to other oral bisphosphonates responsible? J Bone Miner Res 23:2\u20135","journal-title":"J Bone Miner Res"},{"key":"9161_CR41","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.bone.2003.08.004","volume":"33","author":"DB Burr","year":"2003","unstructured":"Burr DB, Miller L, Grynpas M, Jiliang L, Boyde A, Mashiba T, Hirano T, Johnston CC (2003) Tissue mineralization is increased following 1-year treatment with high doses of bisphosphonates in dogs. Bone 33:960\u2013969","journal-title":"Bone"},{"key":"9161_CR42","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1359\/jbmr.2000.15.4.613","volume":"15","author":"T Mashiba","year":"2000","unstructured":"Mashiba T, Hirano T, Turner CH, Forwood MR, Johnston CC, Burr DB (2000) Suppressed bone turnover by bisphosphonates increases microdamage accumulation and reduces some biocmechanical properties in dog rib. J Bone Miner Res 15:613\u2013620","journal-title":"J Bone Miner Res"},{"key":"9161_CR43","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1056\/NEJMoa074941","volume":"357","author":"KW Lyles","year":"2007","unstructured":"Lyles KW, Colon-Emeric CS, Magaziner JS, Adachi JD, Pieper CF, Mautalen C, Hyldstrup L, Recknor C, Nordsletten L, Moore KA, Lavecchia C, Zhang J, Mesenbrink P, Hodgson PK, Abrams K, Orloff JJ, Horowitz Z, Eriksen EF, Boonen S (2007) Zoledronic acid and clinical fractures and mortality after hip fracture. N Engl J Med 357:1799\u20131809","journal-title":"N Engl J Med"},{"key":"9161_CR44","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa067312","volume":"356","author":"DM Black","year":"2007","unstructured":"Black DM, Delmas PD, Eastell R, Reid IR, Boonen S, Cauley JA, Cosman F, Lakatos P, Leung PC, Man Z, Mautalen C, Mesenbrink P, Hu H, Caminis J, Tong K, Rosario-Jansen T, Krasnow J, Hue TF, Sellmeyer D, Eriksen EF, Cummings SR (2007) Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. N Engl J Med 356:1809\u20131822","journal-title":"N Engl J Med"},{"key":"9161_CR45","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1359\/jbmr.070906","volume":"23","author":"RR Recker","year":"2008","unstructured":"Recker RR, Delmas PD, Halse J, Reid IR, Boonen S, Garcia-Hernandez PA, Supronik J, Lewiecki EM, Ochoa L, Miller P, Hu H, Mesenbrink P, Hartl F, Gasser J, Eriksen EF (2008) Effects of intravenous zoledronic acid once yearly on bone remodeling and bone structure. J Bone Miner Res 23:6\u201316","journal-title":"J Bone Miner Res"}],"container-title":["Calcified Tissue International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-008-9161-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00223-008-9161-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-008-9161-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,15]],"date-time":"2021-09-15T03:38:32Z","timestamp":1631677112000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00223-008-9161-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8,19]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["9161"],"URL":"https:\/\/doi.org\/10.1007\/s00223-008-9161-2","relation":{},"ISSN":["0171-967X","1432-0827"],"issn-type":[{"value":"0171-967X","type":"print"},{"value":"1432-0827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,8,19]]}}}